Original Article
Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner
Article first published online: 17 APR 2012
DOI: 10.1111/j.1349-7006.2012.02261.x
© 2012 Japanese Cancer Association
Additional Information
How to Cite
Osawa, T., Ohga, N., Hida, Y., Kitayama, K., Akiyama, K., Onodera, Y., Fujie, M., Shinohara, N., Shindoh, M., Nonomura, K. and Hida, K. (2012), Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner. Cancer Science, 103: 1038–1044. doi: 10.1111/j.1349-7006.2012.02261.x
Publication History
- Issue published online: 1 JUN 2012
- Article first published online: 17 APR 2012
- Accepted manuscript online: 1 MAR 2012 05:19PM EST
- Manuscript Accepted: 24 FEB 2012
- Manuscript Revised: 17 FEB 2012
- Manuscript Received: 9 DEC 2011
- Abstract
- Article
- References
- Supporting Information
- Cited By
| Filename | Format | Size | Description |
|---|---|---|---|
| cas2261-sup-0001-fS1.eps | image/eps | 1876K | Fig. S1. Migration of mouse tumor endothelial cells (melanoma endothelial cells [EC] and renal cell carcinoma EC) was inhibited by indomethacin. |
| cas2261-sup-0002-fS2.eps | image/eps | 1852K | Fig. S2. PGI2 synthesis in mouse tumor endothelial cells was significantly inhibited by NS-398. |
| cas2261-sup-0003-fS3.eps | image/eps | 1747K | Fig. S3. RO1138452 suppressed mTEC migration by an inhibitory effect on the prostacyclin receptor (IP receptor). |
| cas2261-sup-0004-fS4.eps | image/eps | 1547K | Fig. S4. Tube formation of mouse tumor endothelial cells was inhibited by indomethacin. |
| cas2261-sup-0005-fS5.eps | image/eps | 1670K | Fig. S5. RO1138452 suppressed mouse tumor endothelial cell tube formation by an inhibitory effect on the prostacyclin receptor (IP receptor). |
Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

1349-7006/asset/cas_centre.gif?v=1&s=11108c6693d2a39ca49ee937260cc26f94293b0d)
1349-7006/asset/cas_right.gif?v=1&s=8b26cd26c2b4c8264011a9ddc0ed1cf4aaee0b20)
